Xizhong Shen

9.1k total citations
181 papers, 6.7k citations indexed

About

Xizhong Shen is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Xizhong Shen has authored 181 papers receiving a total of 6.7k indexed citations (citations by other indexed papers that have themselves been cited), including 104 papers in Molecular Biology, 35 papers in Cancer Research and 34 papers in Oncology. Recurrent topics in Xizhong Shen's work include Liver Disease Diagnosis and Treatment (22 papers), RNA modifications and cancer (18 papers) and Advanced biosensing and bioanalysis techniques (16 papers). Xizhong Shen is often cited by papers focused on Liver Disease Diagnosis and Treatment (22 papers), RNA modifications and cancer (18 papers) and Advanced biosensing and bioanalysis techniques (16 papers). Xizhong Shen collaborates with scholars based in China, United States and Germany. Xizhong Shen's co-authors include Ling Dong, Taotao Liu, Chunhui Deng, Ji‐Min Zhu, Rui Xue, Ying Fang, Yanjie Chen, Da Fu, Hao Wu and Hai‐Ning Liu and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Xizhong Shen

176 papers receiving 6.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xizhong Shen China	47	3.9k	1.4k	1.0k	923	799	181	6.7k
Yan Luo China	40	2.3k 0.6×	523 0.4×	730 0.7×	719 0.8×	765 1.0×	201	6.2k
Ling Dong China	40	2.3k 0.6×	956 0.7×	503 0.5×	557 0.6×	740 0.9×	155	4.8k
Liang Chen China	43	4.1k 1.1×	1.0k 0.8×	455 0.4×	669 0.7×	1.8k 2.2×	217	7.3k
Fang Wang China	46	4.9k 1.3×	1.3k 1.0×	868 0.8×	383 0.4×	759 0.9×	415	9.5k
Ping Chen China	46	4.0k 1.0×	1.5k 1.1×	920 0.9×	339 0.4×	1.2k 1.5×	358	7.8k
Jen‐Fu Chiu Hong Kong	46	3.1k 0.8×	569 0.4×	508 0.5×	1.3k 1.4×	851 1.1×	144	7.6k
Jianhui Zhu United States	54	4.5k 1.2×	674 0.5×	1.9k 1.8×	524 0.6×	2.0k 2.5×	154	8.9k
Kam M. Hui Singapore	57	5.3k 1.4×	2.1k 1.5×	630 0.6×	875 0.9×	2.3k 2.8×	201	9.3k
Lili Ding China	40	2.0k 0.5×	553 0.4×	632 0.6×	759 0.8×	616 0.8×	151	4.9k
Crispin R. Dass Australia	54	5.7k 1.5×	1.6k 1.1×	399 0.4×	1.8k 1.9×	1.7k 2.1×	223	11.5k

Countries citing papers authored by Xizhong Shen

Since Specialization

Citations

This map shows the geographic impact of Xizhong Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xizhong Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xizhong Shen more than expected).

Fields of papers citing papers by Xizhong Shen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xizhong Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xizhong Shen. The network helps show where Xizhong Shen may publish in the future.

Co-authorship network of co-authors of Xizhong Shen

This figure shows the co-authorship network connecting the top 25 collaborators of Xizhong Shen. A scholar is included among the top collaborators of Xizhong Shen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xizhong Shen. Xizhong Shen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Shen, Xizhong, Wei Yan, Erlei Zhang, et al.. (2025). Adjuvant PD-1 inhibitors improve recurrence and survival outcomes in high-risk hepatocellular carcinoma patients after curative hepatectomy. European journal of medical research. 30(1). 196–196.

Wang, Fu, Haoyu You, Huahua Liu, et al.. (2025). Silencing PTPN2 with nanoparticle-delivered small interfering RNA remodels tumor microenvironment to sensitize immunotherapy in hepatocellular carcinoma. Acta Pharmaceutica Sinica B. 15(6). 2915–2929. 3 indexed citations

Liu, Wenfeng, Ye Xu, Yifan Ma, et al.. (2025). Alisertib impairs the stemness of hepatocellular carcinoma by inhibiting purine synthesis. Journal of Biological Chemistry. 301(6). 108558–108558. 1 indexed citations

Zhu, Ji‐Min, et al.. (2024). HuR facilitates miR-93-5p-induced activation of MAP3K2 translation via MAP3K2 3′UTR ARE2 in hepatocellular carcinoma. Biochemical and Biophysical Research Communications. 722. 150152–150152. 3 indexed citations

Huang, Yan, Hui Wang, Xudong Liu, et al.. (2024). Beneficial Effects of Traditional Chinese Medicine Fuzheng Huayu on the Occurrence of Hepatocellular Carcinoma in Patients with Compensated Chronic Hepatitis B Cirrhosis Receiving Entecavir: A Multicenter Retrospective Cohort Study. Journal of Clinical and Translational Hepatology. 12(5). 505–515. 2 indexed citations

Zhang, Guangcong, Kang Song, Jun Du, et al.. (2024). Bismuth-based mesoporous nanoball carrying sorafenib for synergistic photothermal and molecularly-targeted therapy in an orthotopic hepatocellular carcinoma xenograft mouse model. Colloids and Surfaces B Biointerfaces. 245. 114279–114279. 2 indexed citations

Hong, Weifeng, Dexiang Zhu, Yanjie Chen, et al.. (2023). Coiled-coil domain-containing 154 promotes colorectal cancer proliferation and metastasis via interacting with minichromosome maintenance complex component 2. Cancer Letters. 578. 216460–216460. 3 indexed citations

Tang, Wenqing, et al.. (2023). Comprehensive Investigation Illustrates the Role of M2 Macrophages and Its Related Genes in Pancreatic Cancer. Medicina. 59(4). 717–717. 3 indexed citations

Zhou, Wei, Ying Fang, Da Zhou, et al.. (2023). Label-Free Detection of T4 Polynucleotide Kinase Activity and Inhibition via Malachite Green Aptamer Generated from Ligation-Triggered Transcription. Biosensors. 13(4). 449–449. 5 indexed citations

10.

Wang, Xiang, Jialei Sun, Guangcong Zhang, et al.. (2022). Iridium Complex-Loaded Sorafenib Nanocomposites for Synergistic Chemo-photodynamic Therapy of Hepatocellular Carcinoma. ACS Applied Materials & Interfaces. 14(33). 37356–37368. 20 indexed citations

11.

Zhou, Ying, Shisong Jing, Sainan Liu, et al.. (2022). Double-activation of mitochondrial permeability transition pore opening via calcium overload and reactive oxygen species for cancer therapy. Journal of Nanobiotechnology. 20(1). 188–188. 69 indexed citations

12.

Zhang, Guangcong, Ning‐Ping Zhang, Hai‐Ning Liu, et al.. (2022). microRNA-106b-5p Promotes Cell Growth and Sensitizes Chemosensitivity to Sorafenib by Targeting the BTG3/Bcl-xL/p27 Signaling Pathway in Hepatocellular Carcinoma. Journal of Oncology. 2022. 1–15. 9 indexed citations

13.

Song, Guangqi, Haisi Dong, Danhui Ma, et al.. (2021). Tetrahedral Framework Nucleic Acid Delivered RNA Therapeutics Significantly Attenuate Pancreatic Cancer Progression via Inhibition of CTR1-Dependent Copper Absorption. ACS Applied Materials & Interfaces. 13(39). 46334–46342. 14 indexed citations

14.

Yu, Xiang‐Nan, Guangcong Zhang, Hai‐Ning Liu, et al.. (2021). Pre-mRNA processing factor 19 functions in DNA damage repair and radioresistance by modulating cyclin D1 in hepatocellular carcinoma. Molecular Therapy — Nucleic Acids. 27. 390–403. 9 indexed citations

15.

Yu, Xiang‐Nan, Yong Deng, Guangcong Zhang, et al.. (2020). Sorafenib-Conjugated Zinc Phthalocyanine Based Nanocapsule for Trimodal Therapy in an Orthotopic Hepatocellular Carcinoma Xenograft Mouse Model. ACS Applied Materials & Interfaces. 12(15). 17193–17206. 37 indexed citations

16.

Yu, Xiang‐Nan, Guangcong Zhang, Jialei Sun, et al.. (2020). Enhanced mLST8 Expression Correlates with Tumor Progression in Hepatocellular Carcinoma. Annals of Surgical Oncology. 27(5). 1546–1557. 11 indexed citations

17.

Yu, Xiang‐Nan, Hongying Guo, Taotao Liu, et al.. (2019). Upregulated calcium‐binding tyrosine phosphorylation‐regulated protein‐a/b regulates cell proliferation and apoptosis and predicts poor prognosis in hepatocellular carcinoma. Journal of Cellular Biochemistry. 121(4). 2938–2949. 6 indexed citations

18.

Liu, Hai‐Ning, Hao Wu, Yanjie Chen, et al.. (2018). Diagnostic and Prognostic Value of Circulating MicroRNAs for Esophageal Squamous Cell Carcinoma: a Systematic Review and Meta-analysis. Journal of Cancer. 9(16). 2876–2884. 9 indexed citations

19.

Yang, Yunsheng, Jing‐Yuan Fang, Xiaozhong Guo, et al.. (2018). Linaclotide in irritable bowel syndrome with constipation: A Phase 3 randomized trial in China and other regions. Journal of Gastroenterology and Hepatology. 33(5). 980–989. 39 indexed citations

20.

Liu, Li‐Li, Da Fu, Yu‐Shui Ma, & Xizhong Shen. (2011). The Power and the Promise of Liver Cancer Stem Cell Markers. Stem Cells and Development. 20(12). 2023–2030. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact